Literature DB >> 21282546

Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.

Charles S Cleeland1, Xin Shelley Wang, Qiuling Shi, Tito R Mendoza, Sherry L Wright, Madonna D Berry, Donna Malveaux, Pankil K Shah, Ibrahima Gning, Wayne L Hofstetter, Joe B Putnam, Ara A Vaporciyan.   

Abstract

PURPOSE: Patients receiving cancer-related thoracotomy are highly symptomatic in the first weeks after surgery. This study examined whether at-home symptom monitoring plus feedback to clinicians about severe symptoms contributes to more effective postoperative symptom control. PATIENTS AND METHODS: We enrolled 100 patients receiving thoracotomy for lung cancer or lung metastasis in a two-arm randomized controlled trial; 79 patients completed the study. After hospital discharge, patients rated symptoms twice weekly for 4 weeks via automated telephone calls. For intervention group patients, an e-mail alert was forwarded to the patient's clinical team for response if any of a subset of symptoms (pain, disturbed sleep, distress, shortness of breath, or constipation) reached a predetermined severity threshold. No alerts were generated for controls. Group differences in symptom threshold events were examined by generalized estimating equation modeling.
RESULTS: The intervention group experienced greater reduction in symptom threshold events than did controls (19% v 8%, respectively) and a more rapid decline in symptom threshold events. The difference in average reduction in symptom interference between groups was -0.36 (SE, 0.078; P = .02). Clinicians responded to 84% of e-mail alerts. Both groups reported equally high satisfaction with the automated system and with postoperative symptom control.
CONCLUSION: Frequent symptom monitoring with alerts to clinicians when symptoms became moderate or severe reduced symptom severity during the 4 weeks after thoracic surgery. Methods of automated symptom monitoring and triage may improve symptom control after major cancer surgery. These results should be confirmed in a larger study.

Entities:  

Mesh:

Year:  2011        PMID: 21282546      PMCID: PMC3068055          DOI: 10.1200/JCO.2010.29.8315

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  19 in total

1.  Comparison of drinking patterns measured by daily reports and timeline follow back.

Authors:  J S Searles; J E Helzer; D E Walter
Journal:  Psychol Addict Behav       Date:  2000-09

2.  Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education.

Authors:  J C Mundt; G N Clarke; D Burroughs; D O Brenneman; J H Griest
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

3.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

4.  Chronic post-sternotomy pain.

Authors:  E Kalso; S Mennander; T Tasmuth; E Nilsson
Journal:  Acta Anaesthesiol Scand       Date:  2001-09       Impact factor: 2.105

5.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

6.  Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control.

Authors:  John H Greist; Isaac M Marks; Lee Baer; Kenneth A Kobak; Keith W Wenzel; M Joyce Hirsch; Julia M Mantle; Cathryn M Clary
Journal:  J Clin Psychiatry       Date:  2002-02       Impact factor: 4.384

7.  Telephone-linked care for cancer symptom monitoring: a pilot study.

Authors:  Kathi H Mooney; Susan L Beck; Robert H Friedman; Ramesh Farzanfar
Journal:  Cancer Pract       Date:  2002 May-Jun

8.  Oncology outpatient and provider responses to a computerized symptom assessment system.

Authors:  Janet S Carpenter; Susan Rawl; Jennifer Porter; Karen Schmidt; Jennifer Tornatta; Foluso Ojewole; Paul Helft; David A Potter; Christopher Sweeney; R Brian Giesler
Journal:  Oncol Nurs Forum       Date:  2008-07       Impact factor: 2.172

9.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

10.  The Automatic Patient Symptom Monitor (APSM): a voice mail system for clinical research.

Authors:  B J Marshall; S R Hoffman; V Babadzhov; M Babadzhov; R McCallum
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1993
View more
  114 in total

1.  Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients' supportive care needs.

Authors:  Claire F Snyder; Amanda L Blackford; Jonathan Sussman; Daryl Bainbridge; Doris Howell; Hsien Y Seow; Michael A Carducci; Albert W Wu
Journal:  Qual Life Res       Date:  2014-11-15       Impact factor: 4.147

2.  Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers' use of the information: a randomized controlled clinical trial.

Authors:  Kathi H Mooney; Susan L Beck; Robert H Friedman; Ramesh Farzanfar; Bob Wong
Journal:  Support Care Cancer       Date:  2014-04-01       Impact factor: 3.603

3.  What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer.

Authors:  Meagan S Whisenant; Faith A Strunk; Debasish Tripathy; Loretta A Williams
Journal:  Support Care Cancer       Date:  2019-04-02       Impact factor: 3.603

4.  Reflections on the implementation of screening for distress (sixth vital sign) in Canada: key lessons learned.

Authors:  Margaret I Fitch; Fred Ashbury; Irene Nicoll
Journal:  Support Care Cancer       Date:  2018-06-01       Impact factor: 3.603

5.  Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.

Authors:  Larissa A Meyer; Alpa M Nick; Qiuling Shi; Xin Shelley Wang; Loretta Williams; Tremaine Brock; Maria D Iniesta; Kelly Rangel; Karen H Lu; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2015-01-31       Impact factor: 5.482

6.  A randomized trial of weekly symptom telemonitoring in advanced lung cancer.

Authors:  Susan E Yount; Nan Rothrock; Michael Bass; Jennifer L Beaumont; Deborah Pach; Thomas Lad; Jyoti Patel; Maria Corona; Rebecca Weiland; Katherine Del Ciello; David Cella
Journal:  J Pain Symptom Manage       Date:  2013-11-07       Impact factor: 3.612

7.  Patient-Reported Symptom Interference as a Measure of Postsurgery Functional Recovery in Lung Cancer.

Authors:  Qiuling Shi; Xin Shelley Wang; Ara A Vaporciyan; David C Rice; Keyuri U Popat; Charles S Cleeland
Journal:  J Pain Symptom Manage       Date:  2016-08-10       Impact factor: 3.612

8.  Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.

Authors:  William A Wood; Allison M Deal; Amy Abernethy; Ethan Basch; Claudio Battaglini; Yoon Hie Kim; Julia Whitley; Charlotte Shatten; Jon Serody; Thomas Shea; Bryce B Reeve
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-16       Impact factor: 5.742

9.  Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.

Authors:  Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-27       Impact factor: 4.254

10.  Using the EORTC-QLQ-C30 in clinical practice for patient management: identifying scores requiring a clinician's attention.

Authors:  Claire F Snyder; Amanda L Blackford; Toru Okuyama; Tatsuo Akechi; Hiroko Yamashita; Tatsuya Toyama; Michael A Carducci; Albert W Wu
Journal:  Qual Life Res       Date:  2013-03-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.